. Background: Antimicrobial administration is a risk factor for gastrointestinal disease in horses. Dysbiosis, or changes in the gastrointestinal bacteria, may subsequently result in alterations of metabolic function.
Methods: Metronidazole (15 mg/kg po q12 h) was administered to adult horses (n = 5) with indwelling cecal cannulas. Fecal and cecal microbiota and metabolite profiles were characterized by Illumina sequencing of 16 S rRNA genes and by an untargeted metabolomics approach using mass spectrometry platforms.
Results: Metronidazole significantly decreased measures of alpha diversity in both fecal (Shannon, P = 0.021) and cecal samples (Chao1, P = 0.043; Observed OTUs, P = 0.001; Shannon, P = 0.002). Beta diversity, as measured by weighted Unifrac distances, showed significant decreases in both cecal and fecal samples (ANOSIM, P = 0.001). The bacterial taxa Christensenellaceae, Campylobacteriaceae, and Spirochaetaceae were significantly altered due to antibiotic administration. Of the 553 metabolites analyzed, 223 were named and 330 were unnamed. Analysis of the named fecal metabolites found 110 were significantly different after metronidazole administration (P < 0.05, q = 0.041). In contrast, only 2 cecal metabolites remained significant after adjustment for multiple comparisons (P < 0.05, q = 0.049) had been made. These metabolites were active in the biosynthesis of fatty acids, steroids, proteins, carbohydrates, sucrose, and starches.
Conclusions: Metronidazole administration changed the cecal and fecal microbiome and metabolome in horses. Faculty of Medicine, Department of Surgery & Cancer, Imperial College, London SW7 2AZ. Background: The equine microbiome is extremely sensitive to change, anthelmintic treatment is a colic risk factor (Hillyer et al., 2002) .
Objectives:
The aim was three-fold, does moxidectin; (i) alter bacterial composition (ii) get metabolized by bacteria (iii) alter hind gut fermentation kinetics.
Methods: Seventeen horses, mean 12 AE 3.5 years, kept at pasture, with haylage provided and no concentrates. Faecal Egg Counts were conducted September 2015-March 2016, no eggs seen, no anthelmintic given. Sampling commenced March 2016, points were 0 (prior), 16, 48 and 168 hours post anthelmintic. Treatments were randomized, nine animals dosed orally with Moxidectin 18.92 mg/g at 0.4 mg/kg bw and eight controls. Three horses from each group were randomly assigned for fermentation kinetics. Sequencing of the 16S rRNA gene was conducted on extracted faecal bacterial DNA, bioinformatics using QIIME assigning operational taxonomic units (OTUs). LEfSe (Segata et al., 2011) was used to identify differentially abundant OTUs. Bacterial metabolic profiles were characterized by 1 H NMR spectroscopy (Escalona et al., 2015) , from urine, analysed by Principal Components Analysis. Fermentation of hay and oats, separately, were measured by in vitro gas production (Murray et al., 2006) , data were analysed by repeated measures ANOVA.
Results: There were 13 differing OTU abundances between groups overall. At 16 hours we found 4 differing OTU abundances between groups. 1 H NMR identified no significant metabolite differences. There was a significant reduction in fermentation of both hay (P = 0.04) and oats (P = 0.005) at 16 hours post treatment.
Conclusions:
Moxidectin altered fermentation kinetics of hay and oats, but bacterial diversity did not significantly alter. No change in bacterial metabolite output was detected.
